Tezomib 2 mg Injection
  1. Home
  2. Pharma Products
  3. Bdr Pharmaceuticals Internationalas Pvt Ltd
  4. Tezomib 2 mg Injection

Tezomib 2 mg Injection

Tezomib 2 mg Injection contains bortezomib, a proteasome inhibitor used as an anticancer medicine. It is mainly used for multiple myeloma and mantle cell lymphoma in eligible adults. Bortezomib works by interfering with proteasome activity and promoting cancer-cell death.

BUY NOW

Category

Tezomib 2 mg Injection is administered under specialist supervision as part of treatment protocols for multiple myeloma and mantle cell lymphoma. Bortezomib blocks proteasomes, causing an accumulation of abnormal proteins inside cancer cells and interfering with their survival. It may be given by intravenous or subcutaneous administration according to the prescribed regimen. Regular monitoring is required to assess blood counts, treatment response, and potential adverse effects.

Technical Specification

Specification Details
Active Ingredient Bortezomib
Strength 2 mg
Dosage Form Injection
Route of Administration Intravenous / Subcutaneous
Pack Size 1 Vial
Manufacturer BDR Pharmaceuticals Internationals Pvt Ltd

Product Also Known As

Tezomib 2 mg Injection, Bortezomib 2 mg Injection, Tezomib Bortezomib Injection, Bortezomib Cancer Injection, Proteasome Inhibitor Injection, Multiple Myeloma Treatment Injection